372 Inverness Dr Englewood, CO 80112
Class A Medical Office, 49,106 SF, 22+ Year Lease
Overview
- Added:
- Dec 11, 2024
- Days on market:
- 139
Highlights
- Brand new, Class A, 40-bed inpatient rehabilitation facility (IRF) in affluent southeast Denver.
- Assumable interest-only financing available.
- Expandable to 58 beds.
- Absolute net lease.
- 22-year lease remaining with 2% annual rent increases.
- Strong demographics: 210,000 residents within 5 miles, $146,000 average household income.
Property Details for 372 Inverness Dr
- Property type
- Office properties, Medical offices
- Square Feet
- 49,106 SF
- Class
- A
- Year Built
- 2022
- Buildings
- 1
- Stories
- 3
- Lot Size (sq. ft)
- 130,680 SF
- Units
- 1
Location Insight
- City
- Englewood
- County
- Douglas
- State
- Colorado
- Latitude
- 39.559924686467
- Longitude
- -104.86527371932
Nearby Similar for Sale
FAQs
- What type of property is this?
- Office property - Class A Medical Office, 49,106 SF, 22+ Year Lease
- Where is the office property located?
- The property is located at 372 Inverness Dr Englewood, CO.
- What are key features of this property?
- This property features: Brand new, Class A, 40-bed inpatient rehabilitation facility (IRF) in affluent southeast Denver.; Assumable interest-only financing available.; Expandable to 58 beds.
- How can I contact the broker?
- We strongly encourage to message the broker through our portal by clicking on the “Envelope” icon next to the brokers photo on the property page. We’ve found brokers response time is much quicker via our messaging portal than phone as brokers are always on the go.
- How do I access a private listing?
- Please contact the broker directly with the information provided on the listing. Once the broker approves your credentials he will make the information public to you.
- How do I unsubscribe from emails?
- At the footer of each email you will find links to Reduce Email Frequency, Adjust Email Settings or Unsubscribe altogether. If you choose to Unsubscribe and are still receiving emails please reach out to us at [email protected].